Doctors warn Gen Z's drastic anti-ageing beauty method is making their skin look WORSE
The 'morning shed' trend sees people going to bed plastered in face masks, eye masks, chin straps, mouth and face tape, and bonnets in a bid to achieve glowing 'glass skin' by morning.
'The uglier you go to bed, the hotter you wake up' has become the mantra of many social media users, such as American TikToker Ashley West, who boasts one million followers, as they layer up before bedtime.
The popular, but time consuming, process sees people peeling off the many layers in the morning as they get ready for the day.
But despite the great amount of effort, experts have warned that it might all be in vain.
Dr Anjali Mahto said face-taping - the process of putting kinesiology tape on your face to restrict the muscle movement and try stop wrinkles forming - is an ineffective way of stopping the ageing process.
The consultant dermatologist and founder of the Self London clinic told The Guardian: 'Wrinkles are not just about movement, they involve collagen loss, changes in fat distribution… Taping cannot reverse or prevent those processes.
'At best, it offers a fleeting sense of control. At worst, it disrupts the barrier and causes unnecessary inflammation.'
Creator are often seen wearing silicone patches, sometimes filled with reactive productive such as retinol, which can cause irritation when pressed into the skin over night
Influencers are often seen wearing patches on their foreheads or under their eyes, sometimes filled with reactive products such as retinol, which can cause irritation when pressed into the skin over night.
Another consultant dermatologist told The Guardian the compulsive use of collagen masks to sleep in has shown no proof of having any benefit.
Dr Cristina Psomadakis said: 'Not only is there an environmental impact, but there's also no solid evidence that applying collagen topically replenishes the body's own collagen stores.'
The combination of random serums and lotions that women are adding beneath these masks are also causing irritation.
Cristina, the medical director of prescription skincare brand Klira, added that the 'biggest problem' most dermatologists are seeing these days is people 'overdoing it' by following skincare trends.
Her advice for the most effective routine was to just wash your face at the end of the day and keep steps minimal by only using cleanser, moisturiser, sunscreen in the morning, and sometimes a prescription treatment at night.
However, there is evidence that mouth taping may be used to stop snoring and improve sleep with researchers at Harvard Medical School saying the adhesives 'significantly reduced' oxygen levels and 'hampered breathing'.
Dr Mahto said that people are feeling pressured to not just have a polished appearance but a polished process in a bid towards a curated life.
'Skincare has not been spared, and these increasingly complex night-time rituals often go beyond what the skin physiologically requires, and instead reflect a broader cultural compulsion toward perfection,' they explained.
Last year, dermatologist Sophie Momen told Healthline that the long process is more than likely to simply be 'very time consuming and largely unnecessary'.
She warned that stamping endless products into the skin overnight can be counterintuitive to optimising skin health.
She explained: 'Drenching the skin in heavy serums and products may block pores and lead to breakouts, while around the delicate eye area, it may cause the formation of milia.'
Further, using harsh ingredients with active ingredients that cause irritation since these products are only meant to be used for a short period of time and should be breathable rather than pushed beneath silicone.
Not only can it be damaging, but most products will achieve their intended effect after 10 minutes with little to suggest a further eight hours will better the results.
Though she does believe that some elements can be helpful, for example using silk wraps or pillow cases to reduce harm to our hair at night, the rest isn't likely to reap any improvement in skin quality.
Not to mention, many complain that products and attachments are prone to falling off over night, likely making for a more irritating an uncomfortable night rather than one 'better sleep quality'.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Independent
25 minutes ago
- The Independent
We weren't actually more anxious during Covid, researchers discover
You weren't actually more anxious during the Covid pandemic. Scientists say that anxiety levels among U.S. adults appear to have stayed steady during that period, with new research challenging the belief that there was a widespread spike in psychological distress. Previous research had found a 25 percent increase in the prevalence of anxiety and depression, which the World Health Organization said was linked to feelings of loneliness and fear of infection during the pandemic. The new research, which surveyed nearly 100,000 U.S. adults between 2011 and 2022, found that there was no prolonged spike in anxiety levels for younger or older adults. 'Our results might suggest that the mental health of U.S. adults is more resilient than public perception suggests, given the many news headlines about the U.S. currently experiencing a 'mental health crisis,'' Noah French, a researcher at University of Virginia and an author of the new study, explained in a statement. The pandemic was cited by Biden administration officials as worsening America's mental health crisis in 2023, and the Centers for Disease Control and Prevention now says nearly one in four U.S. adults report having a mental illness. Some 38 percent more people had been in mental health care since the onset of the pandemic, researchers said. The pandemic disproportionately affected the mental health of younger adults, WHO has reported. The isolating impact of school closures also resulted in anxious kids who were academically behind their peers, according to an analysis in The New York Times, and dozens of related studies. However, the new study found that while those aged 18-25 showed significantly stronger symptoms of anxiety compared to older adults during the pandemic, young adults' anxiety levels did not increase from 2011 to 2022 overall. The reasons behind these observations in younger and older adults are unclear. Other surveys have found that Americans are feeling more anxious in general. Polling data from last year found that 43 percent of U.S. adults felt more anxious than they did the previous year and in 2022, according to the American Psychiatric Association. This uptick in American anxiety stems from current events, the economy, and gun violence, the association said. And of the more than 2,200 adults surveyed, 63 percent said they were anxious about their health. It's also possible that worsening mental health was the reason Americans drank more alcohol during the pandemic, according to doctors. One study suggested that mothers with young children drank 300 percent more alcohol than they did before Covid. French said that more research is needed to fully understand what happened, and cautioned against drawing firm conclusions on anxiety levels from his findings. For one, participants skewed younger, were more educated, and had all signed up to answer the questions. That means that they might not be entirely representative of the average American. 'One of my biggest personal takeaways from this project is that there is surprisingly little high-quality research tracking the mental health of entire populations over time,' French said. 'We need a lot more research in this space, and I will forever be skeptical of headlines that make strong claims about a certain mental health condition being 'on the rise.''
Reuters
26 minutes ago
- Reuters
Schrödinger stops development of blood cancer therapy after two patient deaths
Aug 14 (Reuters) - Schrödinger (SDGR.O), opens new tab said on Thursday it has stopped the development of an experimental drug after the death of two patients with a type of blood cancer in an early-stage trial, sending its shares down nearly 17% before the bell. The company was testing the therapy, SGR-2921, in patients with high-risk myelodysplastic syndromes, a group of blood cancers in which the bone marrow doesn't produce enough healthy blood cells, and its more serious form - acute myeloid leukemia. The drug was considered to have contributed to the deaths of two AML patients in the trial, the company said. "While disappointing given the early clinical activity observed, we believe this is the right decision for patients," Chief Medical Officer Margaret Dugan said. In pre-clinical trial, the therapy showed responses against the cancer, which suggested SGR-2921 could ultimately be used in combination with standard of care treatments, the company said. The experimental drug was designed to work by blocking CDC7, a protein that helps cancer cells repair DNA damage during replication. By inhibiting this protein, the drug causes cancer cells to accumulate fatal levels of DNA damage.
Daily Mail
26 minutes ago
- Daily Mail
The hospitals with the LONGEST waiting lists revealed: As 7.37million people wait for routine treatment, the Government is slammed for 'misleading' public on NHS figures
The number of people in England waiting for routine hospital treatment has surged for the first time since March. More than 7.37million treatments—relating to 6.23million patients— are now in the queue for ops like hip replacements, official data revealed today. This includes over 190,000 people stuck in limbo for at least a year, often in pain. While the figure for June marks a drop on the record 7.77million treatments logged in September 2023, it is up almost 10,000 on May. Separate NHS monthly performance data today also revealed around 1,000 patients faced waits of at least 12 hours in A&E every day in June. Experts slammed the 'unacceptable' toll being heaped on patients, warning that A&E clinicians are 'reporting this week as one of the worst they have experienced'. It comes just hours after a leading think tank warned the NHS and the Government had 'misled' the public about the reasons why the waiting list has fallen. Health Secretary Wes Streeting has repeatedly claimed the 260,000 drop in the NHS backlog since the general election 'was not a coincidence', adding that it was because of 'record investment and fundamental NHS reform'. But a new Quality Watch report by the Nuffield Trust think tank found 245,000 appointments were being removed every month because patients died, had treatment elsewhere or moved abroad, rather than because treatment had finished. According to the monthly NHS figures, the number of hospital treatments on the waiting list jumped by 9,712 to 7.37million. Some 191,814—2.6 per cent of those in the backlog — had been waiting at least 12 months. And 1,103 had been waiting for at least 18 months. Although that figure is down from the 1,237 in May. Waiting lists last increased in March before falling for two consecutive months. Responding to the latest figures, Dr Becks Fisher, Nuffield Trust director of research and policy, said the waiting list 'remains stubbornly high'. She added: 'Our new analysis shows that waiting list reductions in previous months are not wholly due to increases in appointments being delivered. In fact, the NHS is still treating fewer patients than are being referred. 'But, an average of about 245,000 cases have been coming off the list each month due to reasons other than patients being recorded as getting their treatment. 'Doing this work to improve the accuracy of the waiting list is important, but we should be under no illusions that despite delivering more appointments, the NHS is still not meeting patient demand.' Elsewhere, new analysis from NHS England found more care was delivered during the most recent doctors' strike compared to a year ago. Resident doctors—formerly known as junior doctors—in England took to the picket lines for five days in July 25 in a dispute with the Government over pay. But, according to the health service, 11,071 more appointments and procedures went ahead during this strike compared to the five-day walkout before the general election in 2024. Staff absences were also lower, it said, with around 1,243 fewer staff absent each day on average compared to last June. Health Secretary Wes Streeting said the figures show the NHS 'was more resilient against last month's strike action than ever before'. 'We are getting on with the job of delivering progress in the face of strike action, and we will continue to put patients first,' he said. Latest A&E figures, however, show 35,467 patients had to wait more than 12 hours last month before being admitted, transferred or discharged. Some 76.4 per cent of patients were seen within four hours in A&Es in July, up from 75.5 per cent in June. The health service's target is 78 per cent. But these figures only look at trolley waits — the time between doctors deciding a patient needs to be admitted and them getting a bed. Figures capturing exact arrival times at A&E paint a much bleaker picture, with 122,852 patients (8.3 per cent) forced to wait at least 12 hours. Dr Nick Murch, president of the Society for Acute Medicine, said: 'These figures again highlight the extent of the crisis across urgent and emergency care, with an unacceptable amount of people waiting over 12 hours in emergency departments, often suffering avoidable harm. 'Clinicians across the UK are reporting this week as one of the worst they have experienced, with no sign of the brief respite seen in the immediate aftermath of recent strike action. 'Yet there remains no tangible and immediate action to address urgent workforce and capacity issues. 'Sadly, instead, recent commentary and reporting suggests a growing reliance on selective or misleading interpretations of NHS data, as highlighted this week in analysis by the Nuffield Trust which calls into question claims the NHS is being turned around. 'This is similar to what is being seen in many urgent and emergency care settings where some areas are being rebranded to 'off the clock' areas improving performance data but not changing the patient journey or experience. Cancer patients also faced longer waits in June—separate NHS figures released today show just one of the three national cancer targets were met. Just 67.1 per cent of newly-diagnosed cancer patients referred for urgent treatment were seen within two months—the target is 85 per cent. Meanwhile, only 91.7 per cent of patients started treatment within 31 days of being booked in June, below the goal of 96 per cent. The health service target of telling at least 75 per cent of patients with suspected cancer they do or don't have the disease was, however, met at 76.8 per cent. But separate ambulance figures for July released by the health service today, found response times had improved. Heart attack and stroke patients in England, known as category two callers, had to wait an average of 28 minutes and 40 seconds for paramedics to arrive on the scene. This is almost a minute quicker than June but ten minutes longer than the 18 minute target. The average category one response time—calls from people with life-threatening illnesses or injuries—was 7 minutes and 56 seconds. This is just 1 second longer than the previous month. The target time is seven minutes. Ambulance teams handled more than 843,535 incidents in July.
